Korean science and technology in an international perspective

Por Mahlich, Jörg., Pascha, Werner.
Publicado em c201

Innovation and technology in Korea challenges of a newly advanced economy /

Por Mahlich, Jörg., Pascha, Werner.
Publicado em c200

Persistence with biologic agents for the treatment of rheumatoid arthritis in Japan

Por Mahlich, Jörg, Sruamsiri, Rosarin
Publicado no Patient Prefer Adherence (2016)

Productivity and deadweight losses due to relapses of schizophrenia in Japan

Por Nakamura, Yusuke, Mahlich, Jörg
Publicado no Neuropsychiatr Dis Treat (2017)

A potential gender bias in assessing quality of life – a standard gamble experiment among university students

Por Obaidi, Leath Al, Mahlich, Jörg
Publicado no Clinicoecon Outcomes Res (2015)

Pharmaceutical regulation in Europe and its impact on corporate R&D

Por Eger, Stephan, Mahlich, Jörg C
Publicado no Health Econ Rev (2014)

Adherence and rehospitalizations in patients with schizophrenia: evidence from Japanese claims data

Por Kuwabara, Hiroyo, Saito, Yoshimichi, Mahlich, Jörg
Publicado no Neuropsychiatr Dis Treat (2015)

Modeling the budget impact of long-acting injectable paliperidone palmitate in the treatment of schizophrenia in Japan

Por Mahlich, Jörg, Nishi, Masamichi, Saito, Yoshimichi
Publicado no Clinicoecon Outcomes Res (2015)

Cost of Illness of Japanese Patients with Chronic Lymphocytic Leukemia (CLL), and Budget Impact of the Market Introduction of Ibrutinib

Por Mahlich, Jörg, Okamoto, Shinichiro, Tsubota, Akiko
Publicado no Pharmacoecon Open (2017)

Estimating Prevalence and Healthcare Utilization for Treatment-Resistant Depression in Japan: A Retrospective Claims Database Study

Por Mahlich, Jörg, Tsukazawa, Sunny, Wiegand, Frank
Publicado no Drugs Real World Outcomes (2017)

Cost-effectiveness of Interferon-free therapy for Hepatitis C in Germany - an application of the efficiency frontier approach

Por Gissel, Christian, Götz, Georg, Mahlich, Jörg, Repp, Holger
Publicado no BMC Infect Dis (2015)

Cost of Depression in Japanese Patients with Rheumatoid Arthritis: Evidence from Administrative Data

Por Guelfucci, Florent, Kaneko, Yuko, Mahlich, Jörg, Sruamsiri, Rosarin
Publicado no Rheumatol Ther (2018)

Cultural beliefs, utility values, and health technology assessment

Por Mahlich, Jörg, Dilokthornsakul, Piyameth, Sruamsiri, Rosarin, Chaiyakunapruk, Nathorn
Publicado no Cost Eff Resour Alloc (2018)

Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database

Por Sruamsiri, Rosarin, Iwasaki, Kosuke, Tang, Wentao, Mahlich, Jörg
Publicado no BMC Dermatol (2018)

Patient preferences for HIV/AIDS therapy - a discrete choice experiment

Por Mühlbacher, Axel C, Stoll, Matthias, Mahlich, Jörg, Nübling, Matthias
Publicado em 2013

Evaluating the concordance of physician judgments and patient preferences on AIDS/HIV therapy - a Discrete Choice Experiment

Por Mühlbacher, Axel C, Stoll, Matthias, Mahlich, Jörg, Nübling, Matthias
Publicado em 2013

Treatment strategies for treatment naïve HIV patients in Germany: evidence from claims data

Por Mahlich, Jörg, Bogner, Johannes R, Tomeczkowski, Jörg, Stoll, Matthias
Publicado no Springerplus (2015)

Preferences Regarding Shared Decision-Making in Japanese Inflammatory Bowel Disease Patients

Por Morishige, Ryuji, Nakajima, Hiroshi, Yoshizawa, Kazutake, Mahlich, Jörg, Sruamsiri, Rosarin
Publicado no Adv Ther (2016)

Treatment pathways of Japanese prostate cancer patients - A retrospective transition analysis with administrative data

Por Cheung, Stephane, Hamuro, Yukinobu, Mahlich, Jörg, Nakayama, Masahiko, Tsubota, Akiko
Publicado no PLoS One (2018)

Simeprevir with pegylated interferon alfa 2a plus ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a meta-analysis and historical comparison

Por Andersohn, Frank, Claes, Anne-Kathrin, Kulp, Werner, Mahlich, Jörg, Rockstroh, Jürgen Kurt
Publicado no BMC Infect Dis (2016)